Specific sessions at the conference will be dedicated to allow researchers and policy makers to present and discuss past and current work in the field of pharmaceutical policies. Contributions to these sessions can be submitted to the organisers of the conference in the form of abstracts.
The sessions will take place on the second day, Friday, 30 September 2011 from 11.30 to 13.00 hours. There will be four parallel sessions, offering different types of presentations (see below).
Please note: For the presentation of pharmaceutical systems in the session on Friday, 30 September 2011 from 9.40 to 11.00 hours, there is a call for posters displaying the pharmaceutical system in countries according to a pre-fined template. This call for posters is independent from this call for abstract.
Abstracts can be submitted electronically through the conference website via online form. The receipt of your abstract will be confirmed by an automatically generated e-mail response indicating the automatically assigned number of reference of your abstract. Please indicate the number of reference in all your communications relating to the abstract.
Abstracts will be reviewed on a rolling basis starting February 28th, 2011.
Final deadline for receipt of abstracts is
April 29th, 2011 June 19th, 2011 (extended deadline!).
An early submission of abstracts is recommended and appreciated.
You will be informed by the end of June / mid of July 2011 if your abstract was accepted and in which form (oral speech, brief oral presentation, poster only; for specifications see below).
When you submit your abstract, please indicate if you would like to present your submission as an oral presentation.
If your abstract is accepted, there are three way of presenting it:
All presentations and posters of the accepted abstracts will be published in the conference documentation, provided receipt of the electronic version by 1 September 2011.
Submitted abstracts are evaluated by the members of the Scientific Programme Committee (link to SPC) or further experts nominated by the Committee.
Topics which will be highly ranked in order to be directly presented at the conference will include
The abstract text must not exceed 3,000 characters (including spaces). The 3,000 characters do not include title, authors, lessons learned and success factors, keywords and funding sources.
Submission should relate to completed or ongoing research (with first results) and must be in English. If English is not your mother tongue, a language check before submitting your abstract is recommended.